G2G Achieves Results
G2G is a bipartisan team of non-dilutive funding experts and government affairs professionals who have spent decades working for and with government on the federal, state and local levels – successfully representing bioscience, healthcare, and high-tech innovators, entrepreneurs, research institutions, companies and nonprofits in securing over $528 million in non-dilutive government funding.
in non-dilutive government funding
WHAT'S TRENDING
LEGISLATIVE UPDATES
SUBSCRIBE
Get the best of G2G sent straight to your inbox.
FOLLOW US ON LINKEDIN
Get all the latest news and updates from us.
Latest From Twitter
Who We Help
BIOSCIENCE & LIFE SCIENCES
BIOTECH INNOVATIONS
HEALTH IT & DIGITAL HEALTH PRODUCTS
NON-PROFITS
HIGH-TECH & TECHNOLOGY POLICIES
MEDICAL DEVICES
THERAPEUTICS
NATIONAL & STATEWIDE ASSOCIATIONS
AEROSPACE
DIAGNOSTICS
TRANSPORTATION INNOVATION
UNIVERSITIES & COLLEGES
“
”
I have been doing Congressional advocacy for several decades. After unsuccessfully trying to get a plus-up for the last three years, we retained G2G, and they were able to get $5 million into the House Appropriations Bill on their first try.
BOB SCHMIDT | CHAIRMAN, NEUROWAVE SYSTEMS INC.
G2G has planned, engineered, and executed an entire, comprehensive initiative to fundamentally change the way our country spends federal dollars on cancer research and development. Liz and her team have blown away every expectation - I could not recommend them enough. They have my unending gratitude, respect, and will continue to be partners with SHEPHERD for a very long time.
DAVID HYSONG | FOUNDER & CHAIRMAN OF THE BOARD, SHEPHERD THERAPEUTICS
“
